Digital health programme following rhythm control in patients with atrial fibrillation: comprehensive disease management by self-monitoring, coaching, and telemedicine
- PMID: 40110209
- PMCID: PMC11914723
- DOI: 10.1093/ehjdh/ztae099
Digital health programme following rhythm control in patients with atrial fibrillation: comprehensive disease management by self-monitoring, coaching, and telemedicine
Abstract
Aims: Digital health is becoming increasingly powerful and available but is frequently not effectively integrated into daily practice. A hybrid programme was developed to provide holistic diagnostic and therapeutic patient care in atrial fibrillation.
Methods and results: Patients (n = 68) were recruited at the electrophysiology centre following successful interventional restoration of sinus rhythm. The 12-month programme consists of the key modalities: (i) self-recording of one-lead electrocardiograms (ECGs), (ii) short-term remote ECG diagnosis and medical advice by video consultation, and (iii) App-based education on lifestyle and risk factor optimization with video consultation. Patients recorded 29 092 ECGs, averaging 1.42 ECGs/day. Recurrent arrhythmia was found and confirmed in 39 patients. In all cases, arrhythmia was first diagnosed based on wearable ECG over the platform, rather than by standard in-office ECG/Holter. No false positive occurred. Patients with recurred arrhythmia were treated by pulmonary vein isolation (n = 17), electric cardioversion (n = 17), antiarrhythmic medication (n = 5), or other interventional procedures (n = 1). Most patients (n = 30) scheduled a video consultation over the App as the first medical touchpoint after arrhythmia occurrence. In 21 patients with arterial hypertension, systolic blood pressure was reduced by 8.0 ± 8.6 mmHg (mean ± SD), P < 0.01. In 25 patients with obesity (body mass index ≥ 30), body weight was reduced by 3.6 ± 5.5 kg (mean ± SD), P < 0.01.
Conclusion: This real-world analysis indicates that the hybrid holistic programme is applicable in daily practice and is actively followed by patients and improves diagnostic and therapeutic outcomes. These promising data need to be confirmed in a controlled randomized study.
Keywords: Atrial fibrillation; Digital medicine; ECG wearable; Telemedicine.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: none declared.
Figures





References
-
- Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024;45:3314–3414. - PubMed
-
- Varma N, Han JK, Passman R, Rosman LA, Ghanbari H, Noseworthy P, et al. Promises and perils of consumer mobile technologies in cardiovascular care: JACC scientific statement. J Am Coll Cardiol 2024;83:611–631. - PubMed
LinkOut - more resources
Full Text Sources